Top 10 Dividend Stocks to Buy in 2026!

McCormick (MKC) is a buy on the dip, offering a duopoly in the global flavor market, a strong dividend history, and significant growth potential from its merger with Unilever's food business.

American Tower (AMT) is a buy due to its monopoly in cell tower real estate, expansion into data centers for AI, and a historically high dividend yield after being beaten down by interest rates.

Pfizer (PFE) is a buy, presenting deep value with a dirt-cheap valuation, a high dividend yield, and strategic acquisitions in key growth areas.

Clorox (CLX) is a buy, offering deep value with strong brands like Pine-Sol and Glad, a high dividend yield, and a decade-low valuation.

Healthcare Realty (HR) is a buy due to its protected medical real estate, demographic tailwinds, and attractive valuation after a post-pandemic slump.

VICI Properties is a strong buy for its stable, resilient business model owning high-value properties with CPI-linked leases and a high dividend yield.

Mid America Apartment Communities is a buy for its strong balance sheet and high rent retention in growing Sun Belt markets, offering an attractive yield.

Medtronic is a buy due to its market leadership, attractive valuation, and strong dividend growth, poised to benefit from an aging population.

Prologis (PLD) is a key player in industrial and logistics real estate, poised to benefit from e-commerce growth and AI infrastructure expansion.

Alexandria Real Estate (ARE) is a top dividend stock with a high yield and significant rebound potential due to its undervalued status.